Vibrio cholerae whole cell antigen

The **Vibrio cholerae whole cell antigen** is a complex mixture of immunogenic molecules obtained from inactivated or killed *Vibrio cholerae* bacteria used for vaccination and immunological research. It includes cell surface antigens (lipopolysaccharide O-antigen, outer membrane proteins, flagellin), secreted proteins (such as cholera toxin), and other structural and metabolic components. The dominant antigenic determinant for serogrouping is the O-antigen of LPS, which defines whether the strain is O1, O139, or another serotype/biotype. Immunization with whole-cell antigen induces broad antibody responses, including vibriocidal antibodies that correlate with protection against cholera. Whole cell antigens are essential components for developing vaccines, studying immune response mechanisms, and for laboratory diagnosis and epidemiology. Most whole-cell vaccines and immunological assays utilize O1 or O139 strains—these cause epidemic and pandemic cholera, and immune responses to the whole-cell antigen are critical for establishing protection after infection or vaccination. The O1 antigen itself is subject to genetic and phase variation, which contributes to *V. cholerae*'s ability to evade immunity and persist in populations. This target is **not a single molecular entity or receptor**, but rather a therapeutic target complex comprised of multiple antigenic components from *Vibrio cholerae* cells. It plays a central role in vaccine design, immunity studies, and cholera prevention.

Other names

Whole-cell Vibrio cholerae antigenVibrio cholerae O1 antigen (when specifically O1 serogroup)Vibrio cholerae O139 antigen (when specifically O139 serogroup)V. cholerae WCA (less common, not standardized)

Induction of antibody-mediated immunity (vibriocidal antibodies, mucosal SIgA); Activation of T cell-independent antibody responses, as cholera LPS is a TI-1 antigen; Generation of protective memory immune responses